QC
CTXR icon

Quent Capital’s Citius Pharmaceuticals CTXR Stock Holding History

Quent Capital’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.84K Buy
4,265
+3,340
+361% +$2.7K ﹤0.01% 1317
2025
Q4 		$719 Buy
925
+817
+756% +$1.02K ﹤0.01% 1492
2025
Q3 		$134 Buy
+108
New +$151 ﹤0.01% 1403
2025
Q2 		– Sell
-108
Closed -$161 – 498
2025
Q1 		$161 Hold
108
– – ﹤0.01% 1288
2024
Q4 		$432 Sell
108
-2
-2% -$13 ﹤0.01% 1278
2024
Q3 		$1.38K Hold
110
– – ﹤0.01% 1253
2024
Q2 		$1.61K Hold
110
– – ﹤0.01% 1236
2024
Q1 		$2.47K Hold
110
– – ﹤0.01% 1206
2023
Q4 		$2.08K Buy
110
+4
+4% +$76 ﹤0.01% 1196
2023
Q3 		$1.81K Buy
106
+34
+47% +$808 ﹤0.01% 1188
2023
Q2 		$2.17K Buy
+72
New +$2.37K ﹤0.01% 1176

Other funds holding CTXR

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
AAG
Asset Advisory Group Kinnelon, New Jersey $229M AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Quent Capital's CTXR Position: Q1 2026 in Review

Quent Capital increased its Citius Pharmaceuticals (CTXR) stake by 361% in Q1 2026, buying an estimated $2.7K and bringing the position to 4,265 shares worth $3.84K. The position accounts for ﹤0.01% of the portfolio, ranked #1317.

Quent Capital first reported a position in CTXR in Q2 2023 and has held it in 11 quarters since. 38 funds tracked by Wall St. Rank hold CTXR as of Q1 2026.

  • Quent Capital held 4,265 shares of Citius Pharmaceuticals worth $3.84K as of Q1 2026.
  • Quent Capital bought 3,340 Citius Pharmaceuticals shares in Q1 2026, an estimated $2.7K.
  • Citius Pharmaceuticals made up ﹤0.01% of Quent Capital's portfolio in Q1 2026, its #1317 holding.
  • Quent Capital first reported a position in Citius Pharmaceuticals in Q2 2023 and has held it in 11 quarters since.
  • 38 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q1 2026.

Based on Quent Capital's 13F filing for Q1 2026, filed 28 Apr 2026.